Related Experiment Video
Updated: Feb 14, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Silencing Artemis Enhances Colorectal Cancer Cell Sensitivity to DNA-Damaging Agents
Hai Liu1, Xuanxuan Wang1, Aihua Huang2
1Department of Radiation Oncology, Sir Run Run Shaw Hospital, Sir Run Run Shaw Institute of Clinical Medicine of Zhejiang University, Hangzhou, P.R. China.
Abstract:
Artemis is a key protein of NHEJ (nonhomologous end joining), which is the major pathway for the repair of IR-induced DSBs in mammalian cells. However, the expression of Artemis in tumors and the influence of silencing Artemis on tumor sensitivity to radiation have not been investigated fully. In this study, we investigated how the expression levels of Artemis may affect the treatment outcome of radiotherapy and chemotherapy in colorectal cancer cells. First, we found that the expression of Artemis is strong in some human rectal cancer samples, being higher than in adjacent normal tissues using immunohistochemical staining. We then knocked down Artemis gene in a human colorectal cancer cell line (RKO) using lentivirus-mediated siRNAs. Compared to the control RKO cells, the Artemis knockdown cells showed significantly increased sensitivity to bleomycin, etoposide, camptothecin, and IR. Induced by DNA-damaging agents, delayed DNA repair kinetics was found by the γ-H2AX foci assay, and a significantly increased cell apoptosis occurred in the Artemis knockdown RKO cells through apoptosis detection methods and Western blot. We also found that the p53/p21 signaling pathway may be involved in the apoptosis process. Taken together, our study indicates that manipulating Artemis can enhance colorectal cancer cell sensitivity to DNA-damaging agents. Therefore, Artemis can serve as a therapeutic target in rectal cancer therapy.
Insights
Silencing the Artemis protein enhances colorectal cancer cell sensitivity to DNA-damaging agents like radiation and chemotherapy. This suggests Artemis is a potential therapeutic target for rectal cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Therapeutics
Background:
- Artemis is crucial for DNA double-strand break repair via nonhomologous end joining (NHEJ) in mammalian cells.
- The role of Artemis expression in tumors and its impact on cancer treatment sensitivity remain incompletely understood.
Purpose of the Study:
- To investigate the effect of Artemis expression levels on the treatment outcomes of radiotherapy and chemotherapy in colorectal cancer.
- To determine if manipulating Artemis can enhance colorectal cancer cell sensitivity to DNA-damaging agents.
Main Methods:
- Immunohistochemical staining of human rectal cancer samples to assess Artemis expression.
- Lentivirus-mediated siRNA to knockdown Artemis in the RKO colorectal cancer cell line.
- Assays for DNA repair kinetics (γ-H2AX foci), cell apoptosis, and Western blot analysis of signaling pathways.
Main Results:
- Artemis expression was found to be higher in rectal cancer tissues compared to adjacent normal tissues.
- Artemis knockdown significantly increased RKO cell sensitivity to DNA-damaging agents (bleomycin, etoposide, camptothecin, IR).
- Delayed DNA repair kinetics, increased cell apoptosis, and involvement of the p53/p21 pathway were observed in Artemis-knockdown cells.
Conclusions:
- Manipulating Artemis expression can enhance colorectal cancer cell sensitivity to DNA-damaging agents.
- Artemis represents a potential therapeutic target for improving rectal cancer treatment efficacy.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Self-Evaluation: Self-Enhancement and Self-Verification
Subviral Agents

